This Healthcare Stock Plunges 31%. Why Its Legal Costs Are Set to Double. -- Barrons.com

Dow Jones12-03

By George Glover

Acadia Healthcare stock was on course for its worst day in more than a quarter of a century on Wednesday, after the operator of psychiatric hospitals cut its earnings outlook due to ballooning legal costs.

Shares plummeted 31% to $11.45 in premarket trading. That would mark the largest percentage decrease for the stock since November 2000, according to Dow Jones Market Data. Futures tracking the S&P 500 were 0.2% higher.

The selloff came after Acadia said it was expecting professional and general liability expenses of $116 million this year, up from $54 million in 2024. It blamed a surge in patient-related litigation for the jump in legal costs.

As a result, Acadia now expects adjusted earnings of $1.94 to $2.04 a share for the year, having previously forecast $2.35 to $2.45 a share.

"The lack of earnings per share visibility will remain a valuation overhang on the stock in the near-term," Mizuho analyst Ann Hynes, who rates the stock at Neutral with a price target of $22, wrote in a research note.

It's the second time in less than a month that Acadia has lowered its full-year earnings outlook. The behavioral healthcare company also cut its guidance on Nov. 5, when it reported better-than-expected third-quarter results.

Write to George Glover at george.glover@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 03, 2025 08:18 ET (13:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment